Market Closed -
Other stock markets
|
After market 05:23:46 am | |||
764 USD | +0.83% | 762.2 | -0.23% |
14/05 | Eli Lilly reaches settlement with spa selling Mounjaro, Zepbound knockoffs | RE |
14/05 | Argus Adjusts Price Target on Eli Lilly to $840 From $770 | MT |
ETFs positioned on Eli Lilly and Company
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.77% | 265 M€ | +5.42% | - | |
0.74% | 57 M€ | +21.00% | - | |
0.72% | 14 M€ | +16.19% | - | |
0.72% | 1,487 M€ | +7.21% | - | |
0.72% | 1 M€ | -.--% | ||
0.66% | 8 M€ | +5.48% | - | |
0.60% | 9 M€ | +9.41% | ||
0.58% | 727 M€ | +8.84% | ||
0.58% | 2,517 M€ | +12.24% | - | |
0.54% | 283 M€ | +19.85% | ||
0.50% | 15 M€ | -1.62% | - | |
0.48% | 0 M€ | 0.00% | - | |
0.47% | 571 M€ | +7.35% | - | |
0.46% | 7 M€ | +0.11% | - | |
0.43% | 391 M€ | +8.80% | - | |
0.43% | 25 M€ | +3.73% | - | |
0.42% | 9 M€ | +9.94% | - | |
0.42% | 34 M€ | +8.28% | - | |
0.36% | 4 M€ | -.--% | - | |
0.36% | 35 M€ | +8.00% | - | |
0.36% | 169 M€ | -0.42% | - | |
0.34% | 45 M€ | 0.00% | - | |
0.33% | 112 M€ | +4.91% | - | |
0.31% | 306 M€ | +5.95% | - | |
0.31% | 39 M€ | +5.31% | - | |
0.29% | 6 M€ | +3.89% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+31.06% | 69TCr | |
+31.17% | 59TCr | |
-3.42% | 36TCr | |
+18.02% | 33TCr | |
+4.27% | 29TCr | |
+14.79% | 24TCr | |
+10.11% | 21TCr | |
-7.08% | 20TCr | |
+8.12% | 17TCr | |
-1.42% | 16TCr |
- Stock Market
- Equities
- LLY Stock
- Funds and ETFs Eli Lilly and Company